Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Assets: 2020-2025

Historic Assets for GeneDx Holdings (WGS) over the last 5 years, with Sep 2025 value amounting to $493.9 million.

  • GeneDx Holdings' Assets rose 20.81% to $493.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $493.9 million, marking a year-over-year increase of 20.81%. This contributed to the annual value of $419.4 million for FY2024, which is 0.15% up from last year.
  • Latest data reveals that GeneDx Holdings reported Assets of $493.9 million as of Q3 2025, which was up 6.48% from $463.9 million recorded in Q2 2025.
  • In the past 5 years, GeneDx Holdings' Assets ranged from a high of $933.3 million in Q2 2022 and a low of $175.5 million during Q2 2021.
  • For the 3-year period, GeneDx Holdings' Assets averaged around $443.1 million, with its median value being $419.4 million (2024).
  • Its Assets has fluctuated over the past 5 years, first surged by 431.68% in 2022, then plummeted by 49.66% in 2023.
  • Over the past 5 years, GeneDx Holdings' Assets (Quarterly) stood at $554.1 million in 2021, then fell by 11.40% to $490.9 million in 2022, then fell by 14.70% to $418.8 million in 2023, then grew by 0.15% to $419.4 million in 2024, then increased by 20.81% to $493.9 million in 2025.
  • Its last three reported values are $493.9 million in Q3 2025, $463.9 million for Q2 2025, and $446.4 million during Q1 2025.